Vanguard Group Inc Fortress Biotech, Inc. Transaction History

Vanguard Group Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$0.28 - $0.65 $1,708 - $3,965	6,100 Added 0.12%	5,258,555 $1.52 Million
Q2 2023 Aug 14, 2023	BUY	$0.49 - $0.82 $8,500 - $14,225	17,348 Added 0.33%	5,252,455 $2.89 Million
Q1 2023 May 15, 2023	BUY	$0.65 - $1.1 $84,955 - $143,770	130,700 Added 2.56%	5,235,107 $4.29 Million
Q4 2022 Feb 10, 2023	SELL	$0.48 - $13.5 $188 - $5,305	-393 Reduced 0.01%	5,104,407 $3.37 Million
Q3 2022 Nov 14, 2022	SELL	$0.79 - $22.0 $21,257 - $591,976	-26,908 Reduced 0.52%	5,104,800 $4.39 Million
Q2 2022 Aug 12, 2022	SELL	$0.8 - $1.5 $434,264 - $814,245	-542,830 Reduced 9.57%	5,131,708 $4.31 Million
Q1 2022 May 13, 2022	SELL	$1.24 - $2.75 $19,512 - $43,274	-15,736 Reduced 0.28%	5,674,538 $7.72 Million
Q4 2021 Feb 14, 2022	BUY	$2.42 - $3.65 $714,374 - $1.08 Million	295,196 Added 5.47%	5,690,274 $14.2 Million
Q3 2021 Nov 12, 2021	BUY	$2.82 - $3.7 $62,984 - $82,639	22,335 Added 0.42%	5,395,078 $17.4 Million
Q2 2021 Aug 13, 2021	BUY	$3.5 - $5.48 $18.8 Million - $29.4 Million	5,372,743 New	5,372,743 $19.2 Million

862K

Ticker FBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,735,000
Market Cap $185M
Description
Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets dermatology products, such as Ximino capsules to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris; Targadox for severe acne; Exelderm cream for ringworm and jock itch sympt...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.